RA Capital Management, LLC, 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), sold 2,372,915 shares at $11.24 ($26.5M) on 2014-09-24, disclosed to the SEC on 2014-09-26.
Open-market sale of $26.5M ACHN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.24 | 175,720 | $2.0M | 7.5% |
| 2 | $11.25 | 319,100 | $3.6M | 13.5% |
| 3 | $11.28 | 500,000 | $5.6M | 21.3% |
| 4 | $11.29 | 210,109 | $2.4M | 8.9% |
| 5 | $11.01 | 116,186 | $1.3M | 4.8% |
| 6 | $11.06 | 131,800 |
| $1.5M |
| 5.5% |
| 7 | $11.06 | 250,000 | $2.8M | 10.4% |
| 8 | $10.96 | 120,000 | $1.3M | 5.0% |
| 9 | $11.10 | 250,000 | $2.8M | 10.5% |
| 10 | $11.12 | 300,000 | $3.3M | 12.6% |
| Total | $11.17 avg | 2,372,915 | $26.5M | 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |